CC
AXSM icon

Cannell & Co’s Axsome Therapeutics AXSM Stock Holding History

Cannell & Co’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$6.59M Sell
82,845
-21,345
-20% -$1.43M 0.21% 93
2023
Q3 		$7.28M Sell
104,190
-15,020
-13% -$1.12M 0.25% 93
2023
Q2 		$8.57M Hold
119,210
– – 0.28% 89
2023
Q1 		$7.35M Sell
119,210
-250,810
-68% -$16.5M 0.26% 93
2022
Q4 		$28.5M Buy
370,020
+320,680
+650% +$19.2M 1.03% 32
2022
Q3 		$2.2M Buy
49,340
+43,340
+722% +$2.17M 0.08% 120
2022
Q2 		$230K Buy
+6,000
New +$190K 0.01% 243

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return